News | December 29, 2008

Merit Medical Announces Year-End Developments

December 30, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used in cardiology and radiology procedures, today announced four developments regarding products and approvals.

The company said it has acquired the rights for a radial artery compression device for an undisclosed amount. The device is used to maintain a given pressure following a cardiac procedure, which allows early ambulation.

Merit also acquired a device used for the removal of cuffed catheters, such as hemodialysis catheters, and other products, such as ports. The product has patents pending FDA 510(k) clearance and is sold as a stand-alone product as well as part of a kit. The company did not disclose the purchase price.

Merit also said it received FDA 510(k) for its Miser contrast management system. The product has patents pending and will be released during the first quarter of 2009.

The company also received ISO 13485 certification of its facility in Richmond, VA from BSI, Merit's European Notified Body.

For more information: www.merit.com

Related Content

FDA Approves Vascade MVP Vascular Closure System
Technology | Vascular Closure Devices | December 20, 2018
Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food and Drug...
PerQseal Large Bore Closure Device Launches in Europe
News | Vascular Closure Devices | November 21, 2018
Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for large-bore...
Vascade MVP Reduces Time to Ambulation Follow EP Procedures
News | Vascular Closure Devices | November 11, 2018
The Vascade MVP vascular closure system met its endpoints compared to manual compression in a pivotal clinical study...
Technology | Vascular Closure Devices | November 05, 2018
November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S.
Teleflex Acquires Essential Medical
News | Vascular Closure Devices | October 05, 2018
Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential Medical is a privately...
Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018
Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several clinical trials in the...
Cardiva Medical Announces $41 Million for AMBULATE Vascular Closure Device Trial
News | Vascular Closure Devices | February 21, 2018
Vascular closure device provider Cardiva Medical announced that the company has closed on $11 million in additional...
The bioresorbable Cordis Mynx Grip vascular closure device seals arteriotomies without use of permanent hardware.

The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.

Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomi
Overlay Init